LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

13.02 3.66

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.89

Max

13.12

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-217K -19M
Pardavimai	86K 86K
Pelnas, tenkantis vienai akcijai	-0.29
Pelno marža	-22,540.698
Darbuotojai	75
EBITDA	-228K -19M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+69.1% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	9.36
Ankstesnė uždarymo kaina	13.02

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-23 22:23; UTC

Įsigijimai, susijungimai, perėmimai

BHP Abandons Bid for Anglo American Following New Talks

2025-11-23 22:16; UTC

Įsigijimai, susijungimai, perėmimai

Macquarie Proposes $7.5 Billion Takeover of Logistics Operator Qube

2025-11-23 22:01; UTC

Įsigijimai, susijungimai, perėmimai

Macquarie Proposes $7.5B Takeover of Logistics Operator Qube

2025-11-23 19:00; UTC

Uždarbis

Dell, HP Inc., Alibaba, Zoom, Deere, and More Stocks to Watch This Week -- Barrons.com

2025-11-23 00:50; UTC

Uždarbis

Wall Street Goes on a Wild Ride: 'No One Was Expecting This' -- WSJ

2025-11-22 10:30; UTC

Uždarbis

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

2025-11-22 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

2025-11-22 09:20; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-21 22:42; UTC

Rinkos pokalbiai

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

2025-11-21 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-21 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-21 21:47; UTC

Rinkos pokalbiai

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

2025-11-21 21:43; UTC

Rinkos pokalbiai

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

2025-11-21 20:18; UTC

Rinkos pokalbiai

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

2025-11-21 20:14; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

2025-11-21 19:48; UTC

Rinkos pokalbiai

Precious Metals Fall for the Week -- Market Talk

2025-11-21 19:44; UTC

Uždarbis

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

2025-11-21 19:37; UTC

Rinkos pokalbiai

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

2025-11-21 19:27; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2025-11-21 19:27; UTC

Rinkos pokalbiai

Uždarbis

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

2025-11-21 19:20; UTC

Rinkos pokalbiai

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

2025-11-21 18:44; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

2025-11-21 18:37; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

2025-11-21 18:34; UTC

Rinkos pokalbiai

Uždarbis

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

2025-11-21 18:28; UTC

Uždarbis

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

2025-11-21 18:03; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

2025-11-21 17:24; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-21 17:24; UTC

Rinkos pokalbiai

Intuit Seen on Path to Increase Growth -- Market Talk

2025-11-21 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-21 17:05; UTC

Rinkos pokalbiai

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

69.1% į viršų

12 mėnesių prognozė

Vidutinis 22 USD 69.1%

Aukščiausias 22 USD

Žemiausias 22 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.